Indian Journal of Pharmacy and Pharmacology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Review Article
Author Details :
Volume : 2, Issue : 1, Year : 2015
Article Page : 55-61
Abstract
Alzheimer disease is one of the most complex and challenging neurodegenerative disorders. It has recently received considerable attention, especially in areas related to new treatments. Alzheimer disease is clinically characterized by progressive cognitive decline associated with impairment in activities of daily living and progressive behavioural disturbances throughout the disease course. The cholinergic system plays a vital role for learning and memory, and the memory impairment severity in Alzheimer disease is mainly associated with cholinergic dysfunction. Hence, restoration of cholinergic neurotransmission may help in treating patients with Alzheimer disease. Studies have revealed encouraging results with cholinesterase inhibitors to increase acetylcholine concentrations in the brains of patients with Alzheimer disease.
How to cite : Raja D, Kumaran K A, Sankar C, Selvaraj K, HYPOTHESIS, PROGRESS AND PROBLEMS - CURRENT TREATMENTS FOR ALZHEIMER’S DISEASE: A REVIEW. Indian J Pharm Pharmacol 2015;2(1):55-61
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
